NanoVibronix

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch NanoVibronix and buy or sell other stocks, ETFs, and their options commission-free!

About NAOV

ENvue Medical, Inc. engages in the development of noninvasive biological response-activating devices. The firm's products include UroShield and PainShield. 

CEO
Doron Robert Besser, MD
CEODoron Robert Besser, MD
Employees
14
Employees14
Headquarters
Tyler, Texas
HeadquartersTyler, Texas
Founded
2003
Founded2003
Employees
14
Employees14

NAOV Key Statistics

Market cap
6.88M
Market cap6.88M
Price-Earnings ratio
-0.02
Price-Earnings ratio-0.02
Dividend yield
Dividend yield
Average volume
152.05K
Average volume152.05K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$44.50
52 Week high$44.50
52 Week low
$0.99
52 Week low$0.99

Stock Snapshot

With a market cap of 6.88M, NanoVibronix(NAOV) trades at $6.25. The stock has a price-to-earnings ratio of -0.02.

NanoVibronix(NAOV) stock opened on 2026-05-07 at —. The price climbed to — and dipped to —.

NanoVibronix(NAOV) shares are trading with a volume of 0, against a daily average of 152.05K.

In the last year, NanoVibronix(NAOV) shares hit a 52-week high of $44.50 and a 52-week low of $0.99.

In the last year, NanoVibronix(NAOV) shares hit a 52-week high of $44.50 and a 52-week low of $0.99.

People also own

Based on the portfolios of people who own NAOV. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.